Gemcitabine

“Any of the following single-agent chemotherapy may be given at the discretion of the investigator, with a cycle length not to exceed four weeks: Capecitabine, Vinorelbine,...” NCT01156753 ↗

“Participants will receive 6 cycles of a standard intravenous or oral chemotherapy regimen or an Antibody-Drug Conjugate (ADC), selected by the investigator from...” NCT07371910 ↗

“Gemcitabine will be administered at a calculated dose of 800 mg/m2/BSA every 21 days as concomitant therapy to Nimotuzumab, until 6 cycles are completed, exclusion or death...” NCT02095119 ↗

“Acceptable histology-specific PDC regimens include carboplatin plus paclitaxel or nab-paclitaxel (any histology), carboplatin/cisplatin plus pemetrexed (nonsquamous),...” NCT06865339 ↗

“First-line chemotherapy regimen: gemcitabine combined with albumin-bound paclitaxel or FOLFIRINOX; second-line chemotherapy regimen: If first-line chemotherapy based on...” NCT04677192 ↗

“Successful organoids undergo drug sensitivity testing against a predefined panel of drugs (Gemcitabine + Cisplatin,Gemcitabine + Oxaliplatin,Durvalumab + Gemcitabine +...” NCT07351591 ↗

“Either Paclitaxel 80 mg/m2 as a 1-h infusion, on days 1,8,15,22 every 28 days or Pegylated Liposomal Doxorubicin (PLD) 40 mg/m2 given every 4 weeks or Topotecan 4mg/m2 IV on...” NCT04421547 ↗

“The cohort A (borderline resectable) and cohort B (locally advanced) both received treatment with gemcitabine, albumin paclitaxel (administered on days 1, 8, and 15, with 4...” NCT07208539 ↗

“Gemcitabine + oxaliplatin (GEMOX) regimen chemotherapy: every 21 days (3 weeks), 1000 mg/m2 of gemcitabine was administered intravenously for more than 30 min on the 1st and...” NCT06362317 ↗

“Tivantinib 360 mg twice daily in combination with other anti-cancer therapy (eg, erlotinib,sorafenib, pemetrexed, docataxel, gemcitabine, irinotecan, and/or cetuximab) at the...” NCT01178411 ↗

“Safety & Efficacy of Neoadjuvant Immunotherapy With Durvalumab (MEDI 4736) Combined With Neoadjuvant Chemotherapy (Gemcitabine/Cisplatin or Gemcitabine/Carboplatin) in Patients...” NCT04617756 ↗

“PD-1 inhibitor (200-240mg), gemcitabine (1000mg/m2 on day 1,8) and cisplatin (80mg/m2 on day 1) every three weeks for three cycles as neoadjuvant therapy, then followed by IMRT...” NCT05340270 ↗

“Chemotherapy was either cisplatin (70 mg/m2) or carboplatin (area under the curve [AUC]4·5/AUC5, for glomerular filtration rate <50 mL/min only) administered intravenously on...” PMID 32145825 ↗ Mar 2020

“Gemcitabine as induction chemotherapy, 1000 mg/m2 day 1, 8 per cycle, every 3 weeks for 3 cycles; induction cisplatin 80mg/m2, every 3 weeks for 3 cycles before radiation;...” NCT04605562 ↗

“Patients received 200 mg intravenous tislelizumab on day 1 and intravenous GEMOX (0·5 h of 1000 mg/m2 gemcitabine on days 1 and 8; and 2 h of 85 mg/m2 oxaliplatin on day 1) in...” PMID 40889502 ↗ Aug 2025

“Patients in the TPC arm of the study will be treated with one or a combination of the following: carboplatin, taxanes, capecitabine, gemcitabine, vinorelbine or eribulin in...” NCT06072612 ↗

“Eligible participants will receive QL1706 at 5.0 mg/kg intravenously every 3 weeks, lenvatinib at 8 mg orally once daily every 3 weeks, oxaliplatin at 85 mg/m², and gemcitabine...” NCT06892925 ↗

“This study is an open, single center, exploratory clinical trial aimed at evaluating the safety and efficacy of HRS-4642 in combination with gemcitabine and albumin-bound...” NCT06587061 ↗

“Patients receive Neoadjuvant gemcitabine (1000mg/m2 on day1 and day8 ) and cisplatin (80mg/m2 on day1)every 21days for three cycles followed by concurrent cisplatin (100mg/m2...” NCT03604965 ↗

“the second and third neoajuvant chemotherapy with GP regimen (gemcitabine 1g/m2 d1，8 plus cisplatin 75mg/m2 ) concurrent chemotherapy: single cisplatin (80mg/m2) for two cycle...” NCT05772208 ↗

“Patients receive a 4-week treatment cycle with once-weekly 30-minute gemcitabine infusions beginning one week prior to the first 90Y-hPAM4dose and continuing during the 3...” NCT00603863 ↗

“Standard first-line systemic chemotherapy administered according to institutional guidelines (e.g., modified FOLFIRINOX or gemcitabine plus nab-paclitaxel), followed by...” NCT07407231 ↗

“Based on the PTC results, each participant will receive an individualized neoadjuvant regimen selected from gemcitabine plus cisplatin, disitamab vedotin (RC48), enfortumab...” NCT07690878 ↗

“Control chemotherapy treatment will be chosen from any of the following standard-of-care chemotherapy drugs or combinations: * Liposomal Doxorubicin; * Docetaxel; *...” NCT03949283 ↗

“Cisplatin (75 mg/m2) / Gemcitabine (1250 mg/m2; day 1 and 8) Patients in the chemotherapy arm will receive the treatment until disease progression or unacceptable toxicity...” NCT00446225 ↗

“PD-1 inhibitor plus TP or GP regimen chemotherapy (Paclitaxel or Liposomal Paclitaxel + Carboplatin or Cisplatin , nab-paclitaxel + Carboplatin or Cisplatin, Gemcitabine +...” NCT07337096 ↗

“Participating patients will receive the GnP regimen every 21 days (nab-paclitaxel 125mg/m² ivgtt on days 1 and 8 + gemcitabine 1000mg/m² ivgtt on days 1 and 8, repeated every...” NCT07101679 ↗

“Patients receive concurrent cisplatin 100mg/m2 every 21 days for three cycles during radiotherapy followed by adjuvant gemcitabine (1000mg/m2 on day 1 and day 8) and cisplatin...” NCT03321539 ↗

“The study focuses on advanced metastatic pancreatic cancer, testing a combination of low-dose anti-cancer drugs (G-FLIP: Gemcitabine, Fluorouracil, Leucovorin, Irinotecan, and...” NCT06233877 ↗

“Peritoneal Perfusion Chemotherapy Combined With Gemcitabine and Albumin Binding Paclitaxel Versus Gemcitabine and Albumin Binding Paclitaxel in the Treatment of Advanced...” NCT04707118 ↗

“platinum-based chemotherapy (Carboplatin combined with gemcitabine or paclitaxel or pegylated liposomal doxorubicin) will be administrated by intraveinous route at different...” NCT02891824 ↗

“Induction treatment: 2 cyles of Q3W second-line plantium-based chemotherapy according to standard of care: Cisplatin or carboplatin in combination with pemetrexed, paclitaxel,...” NCT05383001 ↗

“Standard neoadjuvant chemotherapy for muscle-invasive bladder cancer, typically consisting of cisplatin-based regimens such as MVAC (methotrexate, vinblastine, doxorubicin, and...” NCT07202819 ↗

“Carboplatin, cisplatin, paclitaxel, docetaxel, gemcitabine, vinorelbine, pemetrexed, or erlotinib administered on Day 1 of every 21-day cycle except gemcitabine, which was...” NCT00312728 ↗

“Standard of care, gemcitabine-based regimen (single-agent gemcitabine or gemcitabine plus erlotinib) or FOLFIRINOX (combination chemotherapy regimen including 5-fluorouracil,...” NCT01505530 ↗

“The primary objective of this phase I study is to determine the safety, tolerability and optimal tolerated regimen of GW572016 when combined with gemcitabine and with the...” NCT00439179 ↗

“cisplatin + paclitaxel/ albumin-bound paclitaxel/ gemcitabine/ Pemetroxel+ Toripalimab (cisplatin 75mg/m2 (D1), paclitaxel 175mg/m2 (D1), or albumin-bound paclitaxel 260mg/m2...” NCT04606303 ↗

“The treatment regimen was a combination of gemcitabine (1,000 mg/m(2)) on days 1 and 8, cisplatin (80 mg/m(2)) on day 1, and Endostar (15 mg/day) from day 1 to day 14 of a...” PMID 25198661 ↗ 2013

“Patients receive neoadjuvant therapy with gemcitabine(1000mg per square meter on day 1,8) , cisplatin (80mg per square meter on day 1) and tislelizumab(200mg) every three weeks...” NCT04833257 ↗

“A2: gemcitabine 1000mg/m2 on Day 1 vinorelbine 25mg/m2 on Day 1 and Day 8 (GV) A3: docetaxel 75mg/m2 on Day 1 carboplatin AUC5 on Day 1 (DC) A4: gemcitabine 1000mg/m2 on Day 1...” NCT01648517 ↗

“G-FLIP regimen is a combination of low doses (doses lower than those approved by the FDA and used in the clinic) of several anti-cancer drugs, Gemcitabine, Fluorouracil,...” NCT01905150 ↗

“This study is to analyze the safety and efficacy of immunotherapy Triprilumab Injection combined with Gemcitabine Injection plus Cisplatin Injection in patients with advanced...” NCT04413734 ↗

“The "oxaliplatin-based" group will receive gemox (gemcitabine-oxaliplatin, 1x/2 week); alternatively folfox (5 fluorouracil-leucovorin-oxaliplatin, 1x/2 week) or capox...” NCT03217097 ↗

“HAIC-GEMOX: Gemcitabine 1000mg/m2 on Day 1 + Oxaliplatin 85mg/m2 on Day 1, every 3 weeks (Q3W), for up to 6 treatment cycles in combination with Cadonilimab (6mg/kg, D2, Q3W)...” NCT06335927 ↗

“Participants will receive investigator's choice of chemotherapy determined prior to randomization from 1 of the 4 allowed regimens as per protocol: eribulin, or vinorelbine or...” NCT07556848 ↗

“Investigator's choice treatment with chidamide, golidocitinib, mitoxantrone hydrochloride liposome, or gemcitabine hydrochloride administered according to the respective...” NCT07639879 ↗

“Chidamide 20 mg orally;gemcitabine 1g/m2, twice a week, intravenous infusion on day 1, vinorelbine 20 mg/m2, infusion on day 1; Mitoxantrone Hydrochloride Liposome12 mg/m2,...” NCT06211881 ↗

“The aim of this phase II study is to assess the efficacy and safety of sequentially integrated treatment of FOLFIRINOX or Gemcitabine-Abraxane and SBRT in patients with...” NCT03158779 ↗

“Patients with advanced soft-tissue sarcoma (undifferentiated pleomorphic sarcoma, leiomyosarcoma, alveolar soft-part sarcoma) and osteosarcoma will receive selinexor in...” NCT04595994 ↗

“Gemcitabine (Gemzar®), 1000 mg/m2 in 0.9% sodium chloride will be administered as intravenous infusion over 30 minutes, weekly for 3 weeks then rest for 1 week (days 1, 8, 15...” NCT01547260 ↗

“Drugs used in chemotherapy, such as gemcitabine hydrochloride and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells or by...” NCT01089088 ↗

“Nimotuzumab Combined With Toripalimab/Gemcitabine/Cisplatin as First-line Therapy in Patients With Recurrent/Metastatic Nasopharyngeal Carcinoma: a Prospective, Single-arm,...” NCT06509009 ↗

“could be single-agent gemcitabine (1000-1250 mg/m2 intravenously), vinorelbine (25 mg/m2 intravenously or 60 mg/m2 orally), doxorubicin (60-75 mg/m2 intravenously), or best...” PMID 29753703 ↗ May 2018

“The patient with response or stable disease will receive maintenance therapy with one or some of the drugs including bevacizumab, pemetrexed, gemcitabine and docetaxel until...” NCT02701231 ↗

“The other drug must contain one of the following: etoposide, vinorelbine, vinblastine, pemetrexed, taxanes (e.g., paclitaxel, docetaxel, albumin paclitaxel, paclitaxel...” NCT06424899 ↗

“this study aim to evaluate the rate of response and quality of life in patients with locally advanced pancreatic cancer treated with EUS-FNI of gemcitabine in addition to...” NCT07429643 ↗

“investigator selected chemotherapy regimen (paclitaxel, pemetrexed or gemcitabine and other chemotherapeutic drugs which were not administered in the first-line therapy) for a...” NCT05842018 ↗

“standard infusion chemotherapy (including gemcitabine, mitomycin, epirubicin, etc.), dissolved in 50 mL of normal saline or glucose, and intravesical infusion chemotherapy for...” NCT05547516 ↗

“Rituximab combined with Chemotherapy (Rituximab, Cyclophosphamide, doxorubicin, Vincristine, Prednisone, Ifosfamide, Gemcitabine, cisplatin, Carboplatin, Etoposide, MESNA,...” NCT07187960 ↗

“Patients continue to receive standard chemotherapy including folinic acid, fluorouracil, irinotecan and oxaliplatin (FOLFIRINOX), gemcitabine plus nab-paclitaxel, or...” NCT03398291 ↗

“Physician's Choice of carboplatin (preferred) or cisplatin，gemcitabine, taxane (paclitaxel, docetaxel or nab-paclitaxel) or pegylated liposomal doxorubicin，with or without bevacizumab.” NCT05684731 ↗

“One of the following Treatment of Physician Choice will be administered per standard of care: eribulin, ixabepilone, vinorelbine, gemcitabine, paclitaxel, docetaxel, or nab-paclitaxel” NCT01492101 ↗

“Patients receive gemcitabine (1000 mg/m² d1,8), cisplatin (80mg/m² d1), and camrelizumab (200mg, iv drip for over 60min) every 3 weeks for 6 cycles before locoregional radiotherapy.” NCT05431764 ↗

“gemcitabine ：1250mg/m2 (ivdrip) on days 1, oxaliplatin :85 mg/m2 (ivdrip) on day 1, and pegaspargase : 2500 IU/m2 (intramuscular injection) on day 1.Cycle is repeated every 14 days” NCT02080234 ↗

“Nab-paclitaxel 100 mg/m2 IV over 30 minutes on days 1, 8, and 15 along with gemcitabine 1000 mg/m2 IV over 30 minutes on days 1, 8, and 15 in an every 28 day cycle for two cycles.” NCT01470417 ↗

“In our trial we investigated safety and activity of nab-paclitaxel in combination with gemcitabine and oxaliplatin as first-line systemic treatment for patients with advanced BTC.” PMID 38954899 ↗ Jun 2024

“Most common regimen comprised of gemcitabine (1000 mg/ m2 intravenously over 30-60 min) on days 1 and 8, and cisplatin (75 mg/ m2 intravenously over 2 h) on day 1, every 21 days.” NCT06712420 ↗

“Chemotherapy：Vincristine/paclitaxel/docetaxel/pemetrexed/gemcitabine plus cisplatin/carboplatin：administrated for patients with NSCLC requiring post-operative adjuvant therapy.” NCT05834413 ↗

“After 3 weeks Iparomlimab and Tuvonralimab (50 mg/2 mL) on day 1 Albumin-bound paclitaxel 125 mg/m² on days 2 and 9 Gemcitabine 1000 mg/m² on days 2 and 9 Apatinib 250 mg qd” NCT07333287 ↗

“Following lavage with either 80% ethanol (control group) or normal saline (study group), cysts will be injected with a cocktail of 3mg/ml paclitaxel and 19mg/ml gemcitabine.” NCT01475331 ↗

“Neoadjuvant therapy consisting of gemcitabine (1000mg/m2 d1,8) , endostar (150mg 3-day continuous infusion) and envafolimab (240mg d1) was given every 3 weeks for 3 cycles.” NCT06055816 ↗

“Patients will receive nab-paclitaxel 125 mg/m\^2 followed by gemcitabine 1,000 mg/m\^2 as one intravenous infusion over 30-40 minutes on days 1 and 8 of every 21-day cycle.” NCT06722911 ↗

“Investigator's choice of one of the following commercially available products: gemcitabine; capecitabine; fluorouracil with or without leucovorin; irinotecan; or erlotinib.” NCT02004262 ↗

“TSN1611 BID, Paclitaxel (albumin-bound) at 125 mg/m² and gemcitabine at 1000 mg/m² will be administered via intravenous infusion on Days 1, 8, and 15 of each 4-week cycle.” NCT06385925 ↗

“Gemcitabine plus cisplatin induction chemotherapy: gemcitabine is injected intravenously at the dose of 1000 mg/m2 on the 1st and 8th day (within 30 minutes) for 3 cycles” NCT04453826 ↗

“Treatment of relapsed disease with single agent chemotherapy based on physician's choice of weekly paclitaxel, topotecan, pegylated liposomal doxorubicin, or gemcitabine.” NCT02282020 ↗

“azacitidine S.C 25 mg/m2 D1,2,3,4,5 rituximab I.V. 375 mg/m2 D8 gemcitabine I.V. 1,000 mg/m2, D8,15 dexamethasone I.V. or P.O. 40 mg D8,9,10,11 cisplatin 70 mg/m2 I.V. D8” NCT03719989 ↗

“Gemcitabine 1.0 g/m² on day 1, etoposide 60 mg/m² on days 1-3, pegaspargase 2000 IU/m² on day 4, and dexamethasone 40 mg on days 1-4, repeated every 21 days for 1 cycle.” NCT07678229 ↗

“The regimen will comprise gemcitabine (1 000 mg/m(2)) followed by cisplatin (25 mg/m(2)), each administered on days 1 and 8 every 3 weeks (21 day-cycle) for four cycles.” NCT02082522 ↗

“Carboplatin + choice of non-platinum chemotherapy drug: taxane, paclitaxel, nab-paclitaxel, gemcitabine or doxorubicin pegylated liposomal with or without bevacizumab.” NCT02759588 ↗

“Patients will receive reduced intensity chemotherapy with one of three regimens: Busulfan/Fludarabine; Gemcitabine/Fludarabine/Melphalan; Fludarabine/Cyclophosphamide” NCT02098512 ↗

“Selective Internal Radiation Therapy With Yttrium-90 Resin Microspheres Followed by Gemcitabine Plus Cisplatin for Intra-hepatic Cholangiocarcinoma: A Phase II Study” NCT02167711 ↗

“A Phase II Trial of Gemzar (Gemcitabine), Taxol (Paclitaxel), and Platinol (Cisplatin) (GTP) in Treatment of Advanced Transitional Cell Carcinoma of the Urothelium” NCT00310011 ↗

“Gemox: Gemcitabine and Oxaliplatin； IGEV: Ifosfamide, Gemcitabine, Vinorelbine, and Prednisolone； DHAP: Dexamethasone, high-dose Cytarabine (Ara-C) and Cisplatin.” NCT04342936 ↗

“Chemotherapy: Capecitabine Tablets, Gemcitabine Hydrochloride for Injection, Vinorelbine Tartrate Injection and Eribulin Mesylate Injection are Chemotherapy Drugs” NCT07047365 ↗

“combination of chemotherapy (gemcitabine/cisplatin) + trastuzumab + pembrolizumab as first-line treatment for cholangiocarcinoma and gallbladder cancer patients” NCT06178445 ↗

“chemotherapy, single agent including docetaxel, albumin-bound paclitaxel, vinorelbine, gemcitabine, pemetrexed, or paclitaxel, as determined by the investigator” NCT01850147 ↗

“The regimen will consist of gemcitabine (G) administered at a dose of 800 mg/m2, cisplatin (C) 30 mg/m2, and protein-bound paclitaxel (N) 150 mg/m2 administered” NCT04605913 ↗

“Chemotherapy selected by doctors: albumin bound paclitaxel, vinorelbine, gemcitabine, capecitabine, and aribrin were administered according to clinical routine;” NCT04681287 ↗

“GP chemotherapy: Gemcitabine/Cisplatin (gemcitabine 1000mg/m2 + cisplatin 25mg/m2) will be administered on D1/D8 in every three weeks cycle and up to 8 cycles.” NCT05742750 ↗

“HRS-4642 in Combination With Gemcitabine and Albumin-bound Paclitaxel and Adebrelimab will be administrated per dose level in which the patients are assigned.” NCT07131514 ↗

“Patients will recieve 3 cycles of carboplatin and gemcitabine followed by 3 cycles of taxol and carboplatin and then three cycles of adriamycin and topotecan.” NCT00157560 ↗

“Intravesicular therapy will consist of BCG, gemcitabine, mitomycin or a similar drug, depending on institutional standards and treating provider's discretion.” NCT04073160 ↗

“nivolumab and gemcitabine hydrochloride (gemcitabine) as measured by Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 overall response rate (ORR).” NCT03816358 ↗

“Drugs considered acceptable as SSCC: paclitaxel; nab-paclitaxel; eribulin; pegylated liposomal doxorubicin (PLD); vinorelbine; gemcitabine; capecitabine.” NCT01698281 ↗

“Nab-paclitaxel 125 mg/m2, IV infusion over 30 minutes, followed by gemcitabine 1000 mg/m2 as a 30-minute IV infusion on D1, D8, D15 of each 28-day cycle” NCT02125136 ↗

“gemcitabine, pegaspargase, etoposide, and dexamethasone (GPED) in the treatment of Relapsed/Refractory or advanced NK/T-cell lymphoma patients (ENKTCL)” NCT04405375 ↗

“Lapatinib in combination with paclitaxel, letrozole, capecitabine, capecitabine/oxaliplatin, gemcitabine, docetaxel, trastuzumab, FOLFOX4, or FOLFIRI” NCT00790816 ↗

“nab-paclitaxel (120 mg per square meter of body-surface area) followed by gemcitabine (1000 mg per square meter) on days 1, 8, and 15 every 4 weeks.” NCT06601283 ↗

“two-drug chemotherapy group, including gemcitabine-based combination regimens (predominately gemcitabine/nab-paclitaxel or gemcitabine/capecitabine)” NCT06867146 ↗

“Gemcitabine will be given at 1000 mg/m2 IV over 30 minutes on days 1 and 8 of each 21-day cycle of induction chemo (following carboplatin on day 1).” NCT00004093 ↗

“Standard of care regimen for intravenous infusions of gemcitabine and nab-paclitaxel weekly for three weeks followed by one week without an infusion” NCT07562152 ↗

“Patients will receive disease-appropriate systemic chemotherapy for intrahepatic cholangiocarcinoma (gemcitabine/oxaliplatin or gemcitabine alone)” NCT04276090 ↗

“Gemcitabine 1000mg/sqm will be administered by intravenous infusion in accordance with the hospital guidelines for administration of Gemcitabine.” NCT01389414 ↗

“Gemcitabine (1,000 mg/m\^2) will be given by 30-minute intravenous infusion on Day 1, 8, and 15 followed by a one week rest in all 28-day Cycles” NCT02117258 ↗

“Drug: Gemcitabine 1000mg/m2 IV on day 1 and Day 8 of every 3-week cycle, for 2-4 cycles prior to radical nephroureterectomy and lymphadenectomy” NCT04672317 ↗

“Gemcitabine: 1000 mg/m2 in 100 mL of 0.9% sodium chloride injection, administered intravenously over 30 minutes on Days 1 and 8, repeated Q3W.” NCT07599995 ↗

“Adenosine Triphosphate Tumor Chemosensitivity(Oxaliplatin, Gemcitabine, Irinotecan, Paclitaxel,docetaxel, Fluorouracil,Doxorubicin,Cisplatin)” NCT02580253 ↗

“HLX22 (15 mg/kg IV) + trastuzumab (8 mg/kg loading dose → 6 mg/kg maintenance) + nab-paclitaxel (125 mg/m² IV) + gemcitabine (1000 mg/m² IV).” NCT07176702 ↗

“Patients with intrahepatic cholangiocarcinoma will receive Gemcitabine/Oxaliplatin or Gemcitabine alone, at the discretion of the oncologist.” NCT07201519 ↗

“ProAgio combined with Gemcitabine in patients with metastatic TNBC who have been previously treated with at least two prior lines of therapy.” NCT06460298 ↗

“The purpose of this study is to find out if the study drugs nab-paclitaxel, cisplatin, and gemcitabine given together are safe and effective.” NCT03392571 ↗

“GEMOX（intravenous drip，Gemcitabine 1000mg/m2, 2 times every 3 weeks d1+d8; intravenous drip，Oxaliplatin, 100mg/m2, was given every 3 weeks）” NCT06417606 ↗

“nab-paclitaxel (125 mg per square meter of body-surface area) followed by gemcitabine (1000 mg per square meter) on days 1, 8 every 3 weeks” NCT05869474 ↗

“Gemcitabine/Cisplatin (gemcitabine 1000mg/m2 + cisplatin 25mg/m2) will be administered on D1/D8 in every three weeks cycle, up to 6 cycles.” NCT07062328 ↗

“Patients will receive gemcitabine at 1000 mg/m2 and abraxane at 125 mg/m2 intravenously on days 1, 8 and 15 of a 28 day cycle for 2 cycles” NCT01783054 ↗

“Non-squamous carcinoma: pemetrexed + platinum or paclitaxel + platinum Squamous carcinoma: paclitaxel + platinum or gemcitabine + platinum” NCT05798845 ↗

“Possible regimens are either mFOLFIRINOX or NALIRIFOX or Gemcitabine Nab-Paclitaxel ± Cisplatin (GA+/-Cisplatin) or Capecitabine (Xeloda).” NCT06831136 ↗

“The chemotherapy is a fixed regimen, with Gemcitabine at a dose of 1g/m² on day 1 and day 8, and cisplatin at a dose of 80mg/m² on day 1.” NCT06969534 ↗

“Ivonescimab (20mg/kg, Q3W) combined with chemotherapy (pemetrexed 500mg/m², gemcitabine 1000mg/m², or vinorelbine 25mg/m²) for 4 cycles.” NCT06875076 ↗

“Palliative chemotherapy regimen includes Eribulin, Gemcitabine, Utidelone and Vinorelbine, by the treatment of physician's choice (TPC).” NCT06678048 ↗

“AK104 (10mg/kg ,Q3W，intravenously) plus chemotherapy（e.g. gemcitabine or albumin paclitaxel，dosage based on guidelines or instructions）” NCT06427057 ↗

“Drugs used in chemotherapy, such as gemcitabine, work in different ways to stop tumor cells from dividing so they stop growing or die.” NCT00075686 ↗

“intravenous doses of cisplatin 80 mg/m2 on day 1 plus gemcitabine 1000 mg/m2 on days 1 and 8 every 3 weeks for a maximum of 6 cycles.” NCT03664115 ↗

“Gemcitabine 1,000 mg/m\^2 (body surface area) will be administered on day 1, day 8, day 15, day 29, day 36, and day 43, respectively.” NCT00683085 ↗

“Possible platinum doublet chemotherapy regimens are Cisplatin/Carboplatin in combination with Pemetrexed or Docetaxel or Gemcitabine.” NCT06902272 ↗

“Gemcitabine; 1000mg/m2, Day 1, Day 8, 4-cycle administration, Mixed with normal saline 50ml and administered into a vein for 30 min.” NCT04872634 ↗

“GEMOX: gemcitabine 800mg/m2 and oxaliplatin 85mg/m2, intravenous infusion, D2, D15, D29, until 6 cycles of treatment were completed” NCT06320301 ↗

“The GP regimen included gemcitabine administered at a dose of 1 g/m2 on day 1 and day 8, cisplatin at a dose of 80 mg/m2 on day 1.” NCT06669611 ↗

“Phase II Trial of Bortezomib With Combination of Gemcitabine, Ifosfamide and Oxaliplatin (GIFOX-B)in Untreated NK/T Cell Lymphoma” NCT02808091 ↗

“All enrolled patients will first receive a single instillation of gemcitabine (2000mg), followed by the combination therapy phase” NCT07307456 ↗

“The chemotherapy regimen will consist of standard second-line agents such as capecitabine, eribulin, vinorelbine, or gemcitabine.” NCT07657130 ↗

“This arm will receive maximum 8 cycles of gemcitabine 1000 mg/m2 and cisplatin 25 mg/m2 delivered on day 1 and 8 every 3 weekly.” NCT02773485 ↗

“The possible choices as defined by the protocol: * Paclitaxel * Gemcitabine * Pegylated liposomal doxorubicin (PLD) * Topotecan” NCT07546500 ↗

“R-GemOx regimen includes Rituximab Injection, Gemcitabine Hydrochloride for Injection, Gemcitabine Hydrochloride for Injection.” NCT06601504 ↗

“Gemcitabine (1000 mg/m\^2) and Nab-paclitaxel (125 mg/m\^2) administered intravenously on Day 1 and Day 8 of each 3-week cycle.” NCT07312422 ↗

“The GnP regimen is a standard-of-care chemotherapy consisting of Gemcitabine and nab-Paclitaxel administered in 21-day cycles.” NCT07336953 ↗

“GDP, gemcitabine 1000 mg/m2 on days 1 and 8, cisplatin 25 mg/m2 on days 1-3, and dexamethasone 40 mg on days 1-4 every 21 days” PMID 32349779 ↗ Apr 2020

“Gemcitabine will be administered at a dose of 1000 mg/m² on days 1 and 8, and oxaliplatin at 100 mg/m² on day 1 of each cycle.” NCT06941688 ↗

“Gemcitabine will be used for squamous cell carcinomas and pemetrexed will be used for non-squamous non-small cell lung cancer.” NCT01899989 ↗

“Sintilimab intravenous drip, Pegaspargase intramuscular injection, gemcitabine intravenous drip, oxaliplatin intravenous drip” NCT06583083 ↗

“The TAR-200/ gemcitabine (JNJ-17000139) product is an intravesical drug delivery system regulated as an investigational drug.” NCT04919512 ↗

“Methotrexate, Paclitaxel, Docetaxel, Carboplatin, 5-Fluorouracil, Bleomycine, Gemcitabine, Mitomycine or Best supportive care” NCT03088059 ↗

“receive gemcitabine 1000 mg/m2 D1, D8 + oxaliplatin 100 mg/m2, D1 + carrilizumab 200 mg, D1, in 21-day cycles for 6-8 cycles” NCT05919095 ↗

“PD-1 antibody Toripalimab（240mg, iv, q3w），combined with GS regimen(gemcitabine 1000mg／m2 ，d1,d8 + S1 40-60mg bid\*14d，Q21d).” NCT03796429 ↗

“Current guidelines recommend Nab-paclitaxel, Gemcitabine and modified Folfirinox as the first-line chemotherapeutic regimen.” NCT03633734 ↗

“Gemcitabine will be administered (gemzar) intravenously, 1000mg/m2 on Day 1 and Day 8 of a 21 day cycle for up to 4 cycles.” NCT04989218 ↗

“TQB2916 injection combined with gemcitabine and albumin-paclitaxel as first-line treatment for metastatic pancreatic cancer” NCT06962267 ↗

“Gemcitabine and nab-paclitaxel will be administrated by IV infusion, weekly for 3 weeks of a 4 week cycle starting at C1D1.” NCT05586516 ↗

“Gemcitabine/S-1 (G 1000 mg/m2, iv, D1 and 15 plus S-1 60/80/100 mg/day based on BSA, po, D1-7, D15-21, q4w) after the CCRT” NCT01946646 ↗

“chemotherapy may be a)gemcitabine/cisplatin, b)vinorelbine + cisplatin/docetaxel + cisplatin or c)vinorelbine or docetaxel” NCT00642824 ↗

“oxaliplatin 85mg/m2, gemcitabine 1g/m2 D8: Gemcitabine 1g/m2 Three weeks is a course of treatment, a total of 6-8 courses.” NCT04961788 ↗

“Gemox chemotherapy (oxaliplatin + gemcitabine) has been used in the treatment of advanced intrahepatic cholangiocarcinoma” NCT04361331 ↗

“all patients will also receive treatment with carboplatin and either gemcitabine or paclitaxel for a maximum of 6 cycles” NCT00700180 ↗

“Gemcitabine: 1000 mg/m2 over 100 minutes on Day 1 Oxaliplatin: 100 mg/m2 over 120 minutes on Day 2 of every 14 day cycle” NCT01888978 ↗

“Systematic chemotherapy: including capecitabine(1000mg/m2 bid, d1-14, q3w, po), gemcitabine(1000mg/m2, d1,8, q3w, ivgtt)” NCT06230055 ↗

“The chemotherapeutic agents include Doxorubicin, Gemcitabine , Paclitaxel, 5 Fluorouracil , Oxaliplatin, and Irinotecan.” NCT07254091 ↗

“albumin-bound paclitaxel combined with gemcitabine was administered on the first and eighth day, a cycle of three weeks” NCT05035147 ↗

“Drug: Gemcitabine Day 1: Gemcitabine 800mg/mq, Day 4: Gemcitabine 800mg/mq for a maximum of 4 cycles Other Name: Gemzar” NCT05660993 ↗

“Gemcitabine (200mg/l), carboplatin (100mg/l) and paclitaxel (20mg/l) will be each diluted in each in 160ml of NaCl0.9%.” NCT05835804 ↗

“Cisplatin：60mg/m2，Gemcitabine：1g/ m2,Physiological saline 100ml:IV (in the vein) once a week with a total of six times.” NCT02873416 ↗

“gemcitabine was administered by intravenous infusion on days 1 and 8 of each cycle at 1 g/m2 every 3 weeks for 3 cycles” NCT06059261 ↗

“Gemcitabine: 1000 mg/m², intravenous infusion on Day 1 and Day 8 of each 3-week cycle (q3w); for a maximum of 6 cycles.” NCT07263360 ↗

“The choice of chemotherapy plus immunotherapy for squamous cell carcinoma is gemcitabine or paclitaxel or vinorelbine.” NCT06032052 ↗

“Arm 1 and Arm 2 Intravenous CT: cisplatin (75mg/m² at Day 1) and gemcitabine (1250mg/m² at Days 1 and 8) every 3 weeks” NCT00415818 ↗

“Patients will receive three q 21-day cycles of gemcitabine 1000 mg/m2 plus docetaxel 75 mg/m2 plus toripalimab 240 mg” NCT06592599 ↗

“standard doses of cisplatin and gemcitabine (gemcitabine 1000mg /m2 on day 1.8 and cisplatin 70 mg /m2 on day 1, q3w)” NCT07046650 ↗

“Gemcitabine (1000 mg/m²) + saline (100 mL), infused intravenously over 30 minutes, followed by a 100 mL saline flush.” NCT06825546 ↗

“Induction chemotherapy: gemcitabine and cisplatin, Q3W, 3 cycles Concurrent chemotherapy: cisplatin, Q3W, 2-3 cycles” NCT05941741 ↗

“the preferred chemotherapy medicines include Gemcitabine or a three-drug combination chemotherapy called FOLFIRINOX” NCT04931420 ↗

“Paclitaxel (albumin-bound) at 125 mg/m² and gemcitabine at 1000 mg/m² will be administered via intravenous infusion” NCT07259590 ↗

“Gemcitabine: Infused intravenously on Days 1 and 8 of each 3 - week treatment cycle at a daily dose of 1000 mg/m².” NCT06990503 ↗

“GP induction chemotherapy regimen (gemcitabine 1000 mg/m2 D1/8, cisplatin 80 mg/m2 D1, every 3 weeks for 3 cycles)” NCT06301165 ↗

“Chemotherapy list: * Liposomal Doxorubicin; * Docetaxel; * Paclitaxel; * Carboplatin; * Cisplatin; * Gemcitabine;” NCT03632798 ↗

“Gemcitabine will be delivered as a 1000 mg/m² intravenous infusion administered on Day 1 and 8 of a 21-day cycle.” NCT06409429 ↗

“Investigator's choice of monotherapy chemotherapy (Eribulin, Capecitabine, Gemcitabine, Vinorelbine, or Taxanes.)” NCT06775236 ↗

“Gemcitabine + cisplatin: Gemcitabine, 1,000 mg/m², Q3W, d1+d8, IV drip; cisplatin, 80 mg/m², Q3W, d1-3, IV drip.” NCT07328854 ↗

“Panitumumab 2.5 mg/kg on D1, D8, D15, and D22 and Gemcitabine 800 mg/m2 on D1, D8, and D15 of each 28 day cycle.” NCT01296035 ↗

“tislelizumab 200mg, Q3W, lenvatinib 8mg/kg, PO, qd, gemcitabine 1g/㎡, D1, D8, Q3W, oxaliplatin 100mg/㎡, D1, Q3W.” NCT05620498 ↗

“Gemcitabine (1250 mg/m² IV on days 1 and 8) plus Carboplatin (AUC 5 mg/mL•min IV on day 1) of each 3-week cycle.” NCT07053215 ↗

“carreilizumab 200 mg IV D1+ gemcitabine 1000mg/㎡ IV+ albumin binding paclitaxel 125mg/㎡ IV D1.8Q3W; For 6 weeks” NCT06307080 ↗

“Chemotherapy of Physician's Choice, including nab-paclitaxel, Eribulin, Capecitabine, Vinorelbine, Gemcitabine.” NCT07203729 ↗

“Gemcitabine 800 mg/m2 in 250 mL of normal saline, given as fixed dose-rate (FDR, 10 mg/m2/min) infusion, day 1” NCT03406299 ↗

“Gemcitabine (1000mg/m2，d1, 8) + albumin-bound paclitaxel (125mg/m2，d1, 8) , repeat every 3 weeks for 6 cycles” NCT04699539 ↗

“Patients will receive two cycles of gemcitabine, cisplatin, nimotuzumab, and sintilimab as induction therapy.” NCT06490341 ↗

“Gemcitabine: 1000 mg/m² on Day 1 and Day 8; Cisplatin (DDP): 80 mg/m² on Day 1-3; every 3 weeks for 3 cycles” NCT06605131 ↗

“Participants in this study will receive ST-02, a new formulation with gemcitabine once weekly for six weeks.” NCT06124976 ↗

“Chemotherapy regimen is chosen from the following: Vinorelbine, Gemcitabine, taxanes or Eribulin monotherapy” NCT05346861 ↗

“gemcitabine 900 mg/m\^2 over 90 min on Day 1, and gemcitabine 900 mg/m\^2 and docetaxel 75 mg/m\^2 on Day 8.” NCT03742193 ↗

“GEMOX regimen: Gemcitabine 1000mg/m2 will be administered intravenously over 30 minutes on Day 1 and Day 8;” NCT05935579 ↗

“Multimodal ablation combined with pucotenlimab and TPC or sacituzumab govitecan, eribulin,gemcitabine,UTD1” NCT06889610 ↗

“Systemic AG chemotherapy (nab-paclitaxel 125mg/m²+ gemcitabine 1000mg/m², initiated, Day 1,8,15, q4 week)” NCT06946901 ↗

“Gemcitabine 1 gm/m2 IV over 30 minutes on days 1, 8 and 15 every 28 days or day 1 and day 8 every 21 days” NCT00117598 ↗

“carboplatin/gemcitabine, or cisplatin/gemcitabine administered per local standard of care and regulations” NCT02855944 ↗

“NAC-GEMABR regimen includes gemcitabine 1000mg/m2 plus nab-paclitaxel 125mg/m2 3 times weekly 1week rest.” NCT02506803 ↗

“Chemotherapy options include: carboplatin or cisplatin along with pemetrexed, paclitaxel or gemcitabine” NCT06800339 ↗

“FDA approved drugs for the study population: Bevacizumab, Docetaxel, Erlotinib, Gemcitabine, Pemetrexed” NCT02045446 ↗

“* Gemcitabine 1000 mg/m2 IV over 30 minutes on days 1, 8, and 15 (immediately following nab-paclitaxel)” NCT04151277 ↗

“Oncolytic virus d1 ;Camrelizumab 200mg, d2+AG(Gemcitabine d2/9+Capecitabine d2-d15),q3w；up to 4 cycles;” NCT06346808 ↗

“Chemotherapy: DDMVAC (6 cycles) or Gemcitabine-Cisplatin (4 cycles) Immunotherapy: Avelumab (6 cycles)” NCT06686381 ↗

“Patients will receive mono-chemotherapy (Gemcitabine, S-1 or capecitabine) until disease progression.” NCT06422156 ↗

“Patients in the control group receive gemcitabine + oxaliplatin + apatinib as standard chemotherapy.” NCT07330271 ↗

“Gemcitabine 1 000 mg/m2 intravenously on day 1，8; S-1 80 mg/m2 was taken orally twice for two weeks.” NCT05028439 ↗

“Gemcitabine: 1000 mg/m2 IV over 30 minutes; 3 weeks on with 1 week recovery (4 weeks equals 1 cycle)” NCT01764477 ↗

“Gemcitabine and Nab-paclitaxel will be administered on Day 1, Day 8 and Day 15 of each 4 week Cycle.” NCT03329950 ↗

“Investigators choice single agent - Chlorambucil, Rituximab, Cytarabine, Gemcitabine, or Fludarabine” NCT00875667 ↗

“Albumin bound paclitaxel 125mg / m² followed by Gemcitabine 1000mg / m² followed by 2 weeks of rest” NCT05065801 ↗

“possible regimens are either mFOLFIRINOX or Gemcitabine Nab-Paclitaxel +/- Cisplatin (GemAbraxane)” NCT04990609 ↗

“Gemcitabine 1.0g/m2, D1 and D8; Cisplatin 80mg/m2, D1, every 3 weeks per cycle, total three cycles” NCT03907826 ↗

“Drug: Gemcitabine 1000mg/m2, d1 \& 8 of every cycle, every 3 weeks for 3 cycles before radiation.” NCT06712888 ↗

“2 cycles Gemcitabine based chemotherapy before endoscopic surgery, with or without after surgery” NCT05011227 ↗

“5. (Squamous histology) Gemcitabine consolidation 1000mg/m2 days 1,8, every 21 days for 4 cycles” NCT01336543 ↗

“either gemcitabine, 1250 mg/ square meter (m\^2), IV, on Days 1 and 8 of Cycles 1 through 4 or 6” NCT00531960 ↗

“QL1706：5mg/kg，iv，d1 combined with Gemcitabine (1000mg/m2，iv，d1、d8 )or DOCETAXEL (60mg/m2，iv，d1)” NCT07330596 ↗

“CG consists of Gemcitabine 1000 mg/m2 iv in day 1 and day 8 and Cisplatin 70 mg/m2 iv in day 1.” NCT03674424 ↗

“standard of care (SOC) nanoparticle albumin-bound (nab)-paclitaxel (Abraxane) plus gemcitabine.” NCT05557851 ↗

“GEMOX chemotherapy : gemcitabine 1000mg/m2,D1，D8；oxaliplatin 100mg/m2,D1，intravenous infusion.” NCT05430698 ↗

“2. GEMOX chemotherapy : oxaliplatin 100mg/m2，D1, gemcitabine1000mg/m2，D1，intravenous infusion.” NCT06423170 ↗

“GP-2250 plus gemcitabine for safety, tolerability, pharmacokinetics, and biomarker assessments” NCT03854110 ↗

“Gemcitabine 1,000 mg/m² IV on Days 1 and 8 of each 21-day cycle (administered over 30 minutes)” NCT07547592 ↗

“GVD regimen is a chemotherapy regimen consisted by Gemcitabine, Vinorelbine and Doxorubicine.” NCT03346642 ↗

“optional co-administration of gemcitabine (Gem) during dose expansion beginning with Cycle 2.” NCT05085548 ↗

“Gemcitabine 1000 mg/m2, Cisplatin 25 mg/m2 infused on both day 1 and day 8 of a 21-day cycle.” NCT05422690 ↗

“1,000 mg/m2 of gemcitabine and 125 mg/m2 of nab-paclitaxel on days 1, 8, and 15 every 28 days” NCT03443921 ↗

“sequential systemic therapy with ipilimumab N01, sintilimab, nab-paclitaxel, and gemcitabine” NCT07683221 ↗

“gemcitabine 1000 mg/m\^2 intravenous administration \[IV\] q week \[wk\]x3 of 4-week cycles” NCT00711191 ↗

“oxaliplatin 100mg/m2 + Rituxan 375 mg/m2 + Gemcitabine 1000mg/m2 every 2 weeks for 8 cycles” NCT01019863 ↗

“Gemcitabine 1200 mg/m2 intravenously over 30 minutes following the pemetrexed every 14 days” NCT00438204 ↗

“GN: gemcitabine 1000 mg/m\^2 and nab-paclitaxel 125 mg/m\^2, every 21 days (3 weeks/cycle).” NCT06278454 ↗

“gemcitabine 1000 mg/m\^2 and nab-paclitaxel 125 mg/m\^2 on days 1 and 8 of a 21-day cycle” NCT06938503 ↗

“Gemcitabine hydrochloride: 1g/m2, ivgtt, D1, 8 and 15,every 6 weeks for a treatment cycle” NCT06393166 ↗

“Gemcitabine or modified LV5FU (folinic acid+-bolus fluorouracil+ infusional fluorouracil)” NCT02676349 ↗

“gemcitabine 1000 mg/m\^2 and nab-paclitaxel 125 mg/m\^2 on days 1 and 8 of a 21-day cycle” NCT07277452 ↗

“GP (Gemcitabine 1000mg/m2，D1,D8 and cisplatin 25 mg/m2, D1-3 every 3 weeks for 3 cycles）” NCT05622474 ↗

“either rituximab + gemcitabine + oxaliplatin [R-GemOx], or bendamustine + rituximab [BR]” NCT07226752 ↗

“gemcitabine and albumin-bound paclitaxel will be administered at a protocol-defined dose” NCT06835569 ↗

“either rituximab + gemcitabine + oxaliplatin [R-GemOx], or bendamustine + rituximab [BR]” NCT04628494 ↗

“either carboplatin and gemcitabine or carboplatin and paclitaxel followed by DCVAC/OvCa” NCT03657966 ↗

“AG: intravenous nab-paclitaxel 125 mg/m2 and gemcitabine 1000mg/m2 d1,8, q3w, 4 cycles.” NCT06435260 ↗

“Day 1: gemcitabine 1000 mg/m² intravenous (IV) infusion over 100 minutes (10 mg/m²/min)” NCT00552149 ↗

“Gemcitabine plus Albumin-bound Paclitaxel for Injection Regimen: Gemcitabine 1000 mg/m²” NCT07654530 ↗

“Gemcitabine 1000 mg/m² over 30 minutes, followed by Oxaliplatin 100 mg/m² over 2 hours.” NCT06904170 ↗

“Gemcitabine 1000mg/m2 D1, 8 intravenous infusions, 1 course of treatment every 21 days” NCT06636981 ↗

“Gemcitabine 1000mg/m² or Pemetrexed 500mg/m² IV drip on D1 and D8,21 days for a cycle.” NCT02195453 ↗

“Standard of care alone i.e Capecitabine and Oxaliplatin or Gemcitabine and oxaliplatin” NCT05833815 ↗

“cisplatin or carboplatin plus docetaxel, paclitaxel, or gemcitabine for squamous NSCLC” NCT05583188 ↗

“Gemcitabine: 1000 mg/m² intravenous infusion on Days 1 and 8, every 3 weeks per cycle.” NCT07240766 ↗

“standard chemotherapy based on anthracycline or gemcitabine once every 3 weeks (Q3W).” NCT07646080 ↗

“Cisplatin 80 mg/mq iv day 1 and Gemcitabine 1250 mg/mq iv days 1 and 8 every 21 days;” NCT03823625 ↗

“1. JS001 240mg d1, gemcitabine(1g/m²),d1,8 + nedaplatin (80-100mg/m²),d2,q3w,6cycles.” NCT04421469 ↗

“Gemcitabine:800-1000 mg/m2, IV (in the vein) on day 1 and Day 8 of each 21day cycle.” NCT05347134 ↗

“GemOx (gemcitabine 1000mg/m2 plus oxaliplatin 100mg/m2) i.v. on day 2 of each cycle.” NCT07570017 ↗

“gemcitabine + carbo/cis or paclitaxel + carbo or docetaxel + carbo/cis for squamous” NCT06003075 ↗

“GP regimen: Gemcitabine (1000 mg/m2 D1, D8), Cisplatin (60 mg/m2 D1), every 3 weeks” NCT03296306 ↗

“combined with Gemcitabine and Nab-Paclitaxel IV infusion at day1, 8, a 21-day cycle” NCT06266143 ↗

“pemetrexed 500mg per kg q3w/gemcitabine 1000mg per kg q3w and carboplatin AUC=5 q3w” NCT03002844 ↗

“Gemcitabine (1250 mg/m2) IV on D 1, 8. Cisplatin (75 mg/m2) IV on D1 every 3 weeks.” NCT01003964 ↗

“intravenous gemcitabine-oxaliplatin plus toripalimab every 3 weeks for three cycles” PMID 41780001 ↗ Mar 2026

“Gemcitabine 1000mg intravenously on days 1 and 8 every 3 weeks(iv.over 30 minutes)” NCT02844114 ↗

“Gemcitabine(1000 mg/m2 intravenous infusion on Days 1, 8, 15 of each 28-day cycle)” NCT07233850 ↗

“Rituximab, Gemcitabine, Oxaliplatin, Polatuzumab vedotin, Bendamustine, Rituximab” NCT04844866 ↗

“Gemcitabine 1000mg/m\^2 and nab-paclitaxel 125mg/m\^2, administered intravenously” NCT04603586 ↗

“Gemcitabine was administered by IV on days 1 and 8 of each cycle in the TCG arm.” PMID 20733132 ↗ Aug 2010

“Gemcitabine 1000 mg/m\^2 will be administered on Day 1, 8, 15 of a 28-day cycle.” NCT06405685 ↗

“PAXG (cisplatin, nab-paclitaxel, capecitabine, and gemcitabine) over mFOLFIRINOX” PMID 41275879 ↗ Nov 2025

“Patients received gemcitabine (gem) or 5-fluorouracil (5-FU) based chemotherapy.” PMID 40950337 ↗ Aug 2025

“concurrent chemotherapy consisted of gemcitabine at the dose of 600 mg/mq weekly” NCT05399394 ↗

“R-GDP:rituximab 375mg/m\^2 Day 1 (or Day 8), gemcitabine 1g/m\^2 on Days 1 and 8” NCT03391466 ↗

“Daratumumab in combination with Gemcitabine, Dexamethasone and Cisplatin (D-GDP)” NCT04251065 ↗

“Chemotherapy with platinum-based double drugs(Pemetrexed,Gemcitabine,Docetaxel)” NCT03758677 ↗

“Drug: Gemcitabine, Gemcitabine will be administered at a fixed dose of 1000 mg.” NCT05357196 ↗

“platinum based drugs q3wks + Gemcitabine 1250 mg/sm day 1,8 q3wks for 6 cycles.” NCT03923842 ↗

“DCVAC/OvCa is the experimental therapy added on to Carboplatin and Gemcitabine” NCT02107950 ↗

“Second-line: Investigator's choice (pemetrexed, gemcitabine, or vinorelbine).” NCT07131345 ↗

“GC chemotherapy D1 Cisplatin 25mg/m2+ gemcitabine 1g/m2, D8 gemcitabine 1g/m2” NCT04527679 ↗

“Trabectedin 24 h CIV 0.5 mg/m2 D1 and D8 Gemcitabine i.v. 250 mg/m2 D1 and D8” NCT04535271 ↗

“The dose of Gemcitabine 1,000 mg/m2 IV fusion at Day 1, 8, 15 of every cycle” NCT03301805 ↗

“gemcitabine 1250mg/m2, intravenous infusion on day 1 and day 8 of each cycle” NCT04124731 ↗

“Drug: Gemcitabine 1g/m2 intravenously on day 1 and day 8 of a 3 weeks cycle” NCT07304388 ↗

“Drug: SLOG chemotherapy S-1, leucovorin, oxaliplatin, and gemcitabine (SLOG)” NCT06730009 ↗

“gemcitabine 1000 mg/m2 on the first day, arterial infusion for half an hour” NCT06859684 ↗

“chemotherapeutic agent gemcitabine with anti-angiogenic peptide vaccination” NCT00683358 ↗

“Gemcitabine (1000mg/m2) D1 D8+ nidaplatinum (80-100mg/m2) D2 q3w ×4-6cycle” NCT04319471 ↗

“Gemcitabine, 1250mg/m2, d1 d8, Cisplatin, 75mg/m2, d1-d3, 21d, 2-4 cycles.” NCT02876861 ↗

“Squamous: Carboplatin AUC 5 + Gemcitabine 1000mg/m2 or Paclitaxel 200mg/m2” NCT04728724 ↗

“Gemcitabine (Gemzar) 1250 mg/m\^2 IV on Days 1 and 8 of each 3-week cycle.” NCT00281697 ↗

“Gemcitabine 1,000-1,200 mg/m2 intravenously on days 1 and 8 every 21 days.” NCT03472274 ↗

“Rituximab: 375mg/m2, d6; Gemcitabine: 1g/m2, d7 Oxaliplatin: 100mg/m2, d7” NCT06778902 ↗

“gemcitabine(1000mg/m2 by IV infusion on Days 1,8 of each 21-28 day cycle)” NCT03986528 ↗

“Gemcitabine (1000 mg/m2) every three weeks on days 1 and 8 intravenously” NCT06037655 ↗

“Cisplatin and gemcitabine were locally sourced with commercial products.” NCT01342965 ↗

“Gemcitabine plus Cisplatin plus Toripalimab(GP plus Toripalimab regimen)” NCT07362979 ↗

“Gemcitabine: 1000mg/m2, i.v., on Day 1 and Day 8 of each treatment cycle” NCT06573398 ↗

“gemcitabine 1000 mg/m2, D1,D8; cisplatin 80 mg/m2,D1；Q3W, up to 6 cycles” NCT05513573 ↗

“Gemcitabine 1000 mg/m² on Days 1 and 8, administered every 3 weeks (Q3W)” NCT06649448 ↗

“Gemcitabine+Capecitabine or Oxaliplatin+lrinotecan+Calcium folinate+5-FU” NCT07114666 ↗

“Induction chemotherapy with the regimen of gemcitabine plus nedaplatin.” NCT04143984 ↗

“Gemcitabine will be delivered at the dose of 1g/m2 at days 1, 8 and 15.” NCT03199144 ↗

“Name: gemcitabine Dose: 1000 mg/m2 Mode of administration: intravenous” NCT05651269 ↗

“Gemcitabine combined with cisplatin regimen combined with Tislelizumab” NCT06383780 ↗

“Day1 Oxaliplatin 85mg/m2 + gemcitabine 1g/m2, Day 8 gemcitabine 1g/m2;” NCT04523402 ↗

“pemetrexed or gemcitabine in combination with cisplatin or carboplatin” NCT01951586 ↗

“Combination of Nab-paclitaxel 125 mg/m\^2 and Gemcitabine 1000 mg/m\^2” NCT03750669 ↗

“Gemcitabine 1000 mg/㎡ D1, D8 plus Carboplatin AUC=4.5 D1 every 3 weeks” NCT01487915 ↗

“Cisplatin, pemetrexed, gemcitabine, carboplatin, paclitaxel, docetaxel” NCT06623656 ↗

“GemOx regimen: Gemcitabine 1000mg/m2 iv D1, Oxaliplatin 100mg/m2 iv D1” NCT06824883 ↗

“gemcitabine (1000mg/m2 intravenously over 30 minutes on days 1 and 8)” NCT02404571 ↗

“May include carboplatin with gemcitabine, or paclitaxel or pemetrexed” NCT04966676 ↗

“Conventional chemotherapy:gemcitabine and oxaliplatin Drug: Cetuximab” NCT03768375 ↗

“SHR-1210 3mg/kg and Gemcitabine 800 mg/m2 will be administered IV Q2W” NCT03486678 ↗

“squamous: gemcitabine + cisplatin/carboplatin or taxane + carboplatin” NCT04702009 ↗

“Gemcitabine and Cisplatin combined with Clostridium Butyricum Tablets” NCT06696742 ↗

“Gemcitabine 800 mg/m2 on day 1 with a fixed-infusion rate of 80 mins.” NCT06903273 ↗

“FOLFIRINOX or gemcitabine-nab-paclitaxel or gemcitabine monotherapy.” NCT06333314 ↗

“Day1 Oxaliplatin 85mg/m2+ gemcitabine 1g/m2, Day 8 gemcitabine 1g/m2” NCT04506281 ↗

“Gemcitabine 1000 mg/m2 IV over 30 mins on day 1 and day 8 q 3 weekly” NCT07062263 ↗

“Gemcitabine 800 mg/m\^2 intravenous (IV) over 30 minutes for one day” NCT00385788 ↗

“Capecitabine , Vinorelbine, or Gemcitabine combined with trastuzumab” NCT01950182 ↗

“paclitaxel (albumin binding) combined with gemcitabine and cisplatin” NCT04723030 ↗

“Gemcitabine will be given at a dose of 1000 mg/m2 iv over 30 minutes” NCT02261714 ↗

“non-adenocarcinoma, paclitaxel/gemcitabine combined with carboplatin” NCT06136910 ↗

“(gemcitabine 1000mg/m², Nab-paclitaxel 125mg/m², d1, d8, 21d cycle)” NCT06404840 ↗

“Gemcitabine (Gemzar®): 1000 mg/m2 on days 1 and 8 of a 21-day cycle” NCT02492711 ↗

“Gemcitabine 1000 mg/m2 d 1, 8 + cisplatin 75 mg/m2 1 every 3 weeks;” NCT04055038 ↗

“Drug: GP chemotherapy gemcitabine 1000mg/m2 + cisplatin 25mg/m2 Q3W” NCT05023109 ↗

“Drug: GP chemotherapy gemcitabine 1000mg/m2 + cisplatin 25mg/m2 Q3W” NCT05019677 ↗

“gemcitabine 1000mg/m2 on Day 1 and oxaliplatin 100 mg/m2 on Day 2.” NCT02534337 ↗

“Second line therapies will be multi-agent and contain gemcitabine.” NCT03322995 ↗

“Gemcitabine: 1000mg/m2, used on the 1st and 8th day of each cycle;” NCT06241599 ↗

“Drug: Gemcitabine Gemcitabine (1000 mg/m2) on day 1, every 3 weeks” NCT06953739 ↗

“Gemcitabine (G) + Cisplatin (P) + Dexamethasone (DXM)] ± Rituximab” NCT06520163 ↗

“Oxaliplatin 100mg/m2 IV d1 Q3W+ gemcitabine 1000mg/m2 IV d1/8 Q3W” NCT05251662 ↗

“Oxaliplatin 100mg/m2 IV d1 Q3W+ gemcitabine 1000mg/m2 IV d1/8 Q3W” NCT05215665 ↗

“Gemcitabine (1000mg/ m2, intravenous infusion over 30min, d1, 8)” NCT05481476 ↗

“HAIC- GEMOX regimen, gemcitabine 1000 mg/m2, oxaliplatin 85mg/m2” NCT05348811 ↗

“Gemcitabine will be administered by IV infusion on Days 1 and 8.” NCT05852717 ↗

“GEMOX (Cam-GEMOX group; infusional gemcitabine and oxaliplatin)” PMID 34309846 ↗ Sep 2021

“gemcitabine (intravenous infusion of 1000mg/m2 over 30 minutes)” NCT01521702 ↗

“2. gemcitabine 1.0g/m\^2 on day 1 and day 8, intravenous drip;” NCT06314334 ↗

“the combination of gemcitabine and platinum-based chemotherapy” NCT05861830 ↗

“TS (neg), ERCC-1 (pos), Topo I (neg): Capecitabine/Gemcitabine” NCT01394120 ↗

“* Gemcitabine 1000mg/m2 IV over 30 minutes on days 1, 8 and 15” NCT04176952 ↗

“Gemcitabine 1000 mg/m2 d1, 8; Lobaplatin 30mg/m2 d1 q 3 weeks” NCT01483300 ↗

“P-GemOx chemotherapy (Pemetrexed + Gemcitabine + Oxaliplatin)” NCT07542912 ↗

“Gemcitabine: A nucleoside analog that inhibits DNA synthesis.” NCT06829771 ↗

“Gemcitabine, vinorelbine, capecitabine, eribulin or a taxane” NCT02448420 ↗

“standard chemotherapy regimen of gemcitabine and oxaliplatin” NCT06925516 ↗

“Gemcitabine +capecitabine, tislelizumab, neoantigen vaccines” NCT06344156 ↗

“intravenous Gemcitabine 1000 mg/m² and Oxaliplatin 100 mg/m²” NCT07480850 ↗

“GP (gemcitabine: 1000 mg/m2 d1, d8; cisplatin 80 mg/m2) Q3w” NCT05860868 ↗

“Gemcitabine, 800 mg/m², Intravenous, Day 1, 8 every 21 days” NCT03651206 ↗

“Albumin bound paclitaxel 125 mg/m² + Gemcitabine 1000 mg/m²” NCT04570943 ↗

“TGI chemotherapy (nab⁃Paclitaxel+ gemcitabine + ifosfamide)” NCT06816771 ↗

“gemcitabine plus S-1 versus gemcitabine plus nab-paclitaxel” NCT05268692 ↗

“6. Gemcitabine - 800-1250 mg/m2 Days 1 and 8 every 3 weeks” NCT00246571 ↗

“* Gemcitabine: 1000 mg/m\^2 IV, 90 minutes on day 1 and 8.” NCT01696669 ↗

“Gemcitabine：1000mg/m2, vgtt, d1,8, q3w, repeat 4-6 cycles.” NCT06177301 ↗

“and Gemcitabine 1000 mg/m² i.v. (30 min infusion) (Gemzar)” NCT02181101 ↗

“Gemcitabine(G):1000mg/m2 intravenous injection on d1,8 q3w” NCT01669707 ↗

“Gemcitabine 1000 mg/m² en 30 mn IV dans 250 ml NaCl 0,9 %” NCT07128290 ↗

“Gemcitabine, Cisplatin regimen Combined With Camrelizumab” NCT06438627 ↗

“Gemcitabine 1000 mg/m² and oxaliplatin 100 mg/m² IV Day 1” NCT07053150 ↗

“GDP (gemcitabine, cisplatin, dexamethasone) chemotherapy” NCT02276248 ↗

“Gemcitabine (1,000 mg/m2) and nab-paclitaxel (125 mg/m2)” NCT07280377 ↗

“Gemcitabine 1000 mg/m2 on Day 1 and 8 of a 21-day cycle” NCT06389760 ↗

“Gemcitabine, 1000mg/m2，d1, 8, every 3 weeks as a cycle.” NCT06427447 ↗

“Other chemotherapy drugs,such as Docetaxel, gemcitabine” NCT03489616 ↗

“modified gemcitabine-cisplatin neoadjuvant chemotherapy” NCT04588168 ↗

“Drug: Chosen Chemotherapy (Gemcitabine) Gemcitabine -IV” NCT04398108 ↗

“Carboplatin + gemcitabine + pembrolizumab (combination)” NCT05774886 ↗

“gemcitabine (1000mg/m2, intravenous drip, d1, d8, q3w)” NCT04191343 ↗

“Gemcitabine 1000mg/m2, on days 1 and 8, every 3 weeks” NCT07135544 ↗

“* Gemcitabine 1000 mg/m² over 30 minutes at D1 and D8” NCT02591030 ↗

“Gemcitabine 1,000 mg IV on Day 1 and 8, every 3 weeks” NCT04308174 ↗

“Conventional chemotherapy:gemcitabine and oxaliplatin” NCT02836847 ↗

“Gemcitabine (GEM), 800 mg/m2 weekly on Day 1-21, Q28d” NCT02981641 ↗

“with gemcitabine(1000mg/m\^2, iv, Q3W, Day1and Day8)” NCT05781958 ↗

“DNA Intercalators (Capecitabine, 5-FU, gemcitabine)” NCT02299999 ↗

“Gemcitabine (800 mg/m\^2) on day 1,8, every 3 weeks” NCT05299164 ↗

“Gemcitabine: 1000 mg/m2 IV over 30 min; Day 1 and 8” NCT04711824 ↗

“Gemcitabine (G): Intravenous infusion of 1000 mg/m2” NCT07632118 ↗

“patients will be treated with gemcitabine or 5-FU.” NCT02486497 ↗

“Patients receive Gemcitabine (800mg/m2 on day 1,8)” NCT01854203 ↗

“Capecitabine, Eribulin, Gemcitabine or Vinorelbine” NCT01945775 ↗

“the association of Gemcitabine and Cisplatin (GC).” NCT03324282 ↗

“Gemcitabine 1000 mg/m² IV are given on Days 1 \& 8” NCT03581786 ↗

“in combination with gemcitabine and nab-paclitaxel” NCT06944106 ↗

“cisplatin/gemcitabine hydrochloride (gemcitabine)” NCT02567409 ↗

“squamous: carboplatin AUC5, gemcitabine 1000mg/m2” NCT04379739 ↗

“GP: gemcitabine 1g/m2 D1, 8 Cisplatin 80 mg/m2 d1” NCT05520814 ↗

“gemcitabine (1250mg/m2, intravenous drip, D1/D8)” NCT06416930 ↗

“Gemcitabine 1000mg/m2, iv, D1,8,15, 28days/cycle” NCT04324307 ↗

“gemcitabine (1000mg per square meter on day 1,8)” NCT06455410 ↗

“gemcitabine hydrochloride 1g/m2 i.v. over 30 min” NCT05679050 ↗

“gemcitabine(1000mg per square meter on days 1,8)” NCT05193617 ↗

“Gemcitabine 1000 mg/m2 IV on day 1 every 2 weeks” NCT01487720 ↗

“cisplatin-gemcitabine or carboplatin-paclitaxel” NCT00404703 ↗

“Gemcitabine (a nucleoside metabolic inhibitor)” NCT06015659 ↗

“Gemcitabine(1000mg/m2, iv, Q3W, Day1 and Day8)” NCT06013943 ↗

“Gemcitabine (1000 mg/m² IV, days 1 and 8, Q3W)” NCT06735131 ↗

“* or gemcitabine with cisplatin or carboplatin” NCT02178397 ↗

“Gemcitabine: 1250 mg/m², day 1 and 8, i.v., q3” NCT01374789 ↗

“Gemcitabine (1000 mg/m² intravenously, Day 1)” NCT07385989 ↗

“gemcitabine (1250 mg/m\^2 IV) on Days 1 and 8” NCT02000531 ↗

“Gemcitabine 10mg/m²/min IV on day 1, 8 and 15” NCT01964287 ↗

“Active Ingredient:Gemcitabine hydrochloride” NCT03531320 ↗

“cisplatin plus gemcitabine, and gemcitabine” NCT03529279 ↗

“Gemcitabine 1000mg/m2, ivgtt,vdays 1 and 8” NCT06991491 ↗

“Gemcitabine(GEM) 800mg/m2,ivgtt,30min,d1,8” NCT01664975 ↗

“Gemcitabine (GEM): via IV on Days 1 and 8” NCT05634369 ↗

“Cisplatin or Carboplatin With Gemcitabine” NCT01648023 ↗

“Pembrolizumab + Gemcitabine + Carboplatin” NCT06135714 ↗

“Gemcitabine 1250mg/m2 iv days 1 \& days 8” NCT03055312 ↗

“Gemcitabine 1000mg/m2 IV on days 1 and 8” NCT03083808 ↗

“Gemcitabine: IV, 1000mg/m2, Day1, 8, Q3W” NCT05979818 ↗

“Drug: gemcitabine, vincristine,cisplatin” NCT01192633 ↗

“Gemcitabine 800 mg/m2 at day 1 and day 4” NCT01333605 ↗

“Gemcitabine Hydrochloride for Injection” NCT07409428 ↗

“gemcitabine 800mg/m2 on day 1 and day 8” NCT06255795 ↗

“GEM(gemcitabine)1000mg/m2,ivgtt,30,d1、8” NCT02520219 ↗

“Gemcitabine Hydrochloride for Injection” NCT07262567 ↗

“Gemcitabine 1000 mg/m2 IV on days 1 + 8” NCT01496534 ↗

“Gemcitabine 1000 mg/m2 on days -4 + -1” NCT00670631 ↗

“Gemcitabine: 1000 mg/m² ，iv，d1、d8，q3w；” NCT06916975 ↗

“Gemcitabine 900 mg/m² IV in 30 minutes” NCT02386397 ↗

“Drug: Gemox14 Gemcitabine, Oxaliplatin” NCT05381506 ↗

“Gemcitabine 850 mg/m2 + vatalanib 1250” NCT00185588 ↗

“gemcitabine 1000 mg/m2 IV day 1-8 Q3W” NCT07392658 ↗

“Gemcitabine: 1000 mg/m2, IV，d1，d8，Q3W” NCT06654947 ↗

“Gemcitabine:1000 mg/m2, iv, Q3W，D1,D8” NCT05820906 ↗

“Gemcitabine combine with capecitabine” NCT06368063 ↗

“Gemcitabine 1g/m2 Oxaliplatin 100mg/m” NCT05036798 ↗

“Gemcitabine: 1000 mg/m2, IV，d1，d8，Q3W” NCT06062485 ↗

“gemcitabine 1250 mg/m\^2 on D1 and D8” NCT00820755 ↗

“Fludarabine Gefitinib Gemcitabine HCl” NCT02551718 ↗

“Gemcitabine: 1000 mg/m2，iv，d1、d8，q3w” NCT07152769 ↗

“Gemcitabine, 1000mg/m2, i.v., d1, d8” NCT06573151 ↗

“Gemcitabine (800 mg/m\^2) on day 1,8” NCT06244368 ↗

“and 6) combination with gemcitabine.” NCT06840886 ↗

“UGN-301 + gemcitabine in combination” NCT05375903 ↗

“Gefitinib, Gemcitabine, Hydroxyurea” NCT02788201 ↗

“Docetaxel (TXT) + Gemcitabine (GEM)” NCT03121833 ↗

“Gemcitabine and Oxaliplatin (GemOx)” NCT02624492 ↗

“gemcitabine by intravenous infusion” NCT06692166 ↗

“gemcitabine 800mg/m2 iv on days 3,8” NCT02560441 ↗

“GDP：Gemcitabine 800-1000mg/m2, d1、8” NCT04134247 ↗

“* Cisplatin - Gemcitabine (Gem/Cis)” NCT06290687 ↗

“Gemcitabine 1000mg/m2 iv d1 and d8” NCT02194556 ↗

“Rituximab Gemcitabine Oxaliplatin” NCT01670370 ↗

“Nucleoside analogue: Gemcitabine” NCT03257267 ↗

“Gemcitabine, 1.0g/m2/d IV, day 1” NCT02733458 ↗

“gemcitabine 800 mg/m 2 days 1, 8” NCT03154918 ↗

“Gemcitabine 1000mg/m2 on day 1、8” NCT05557578 ↗

“Gemcitabine: 1000 mg/m2, IV, d1” NCT07059650 ↗

“gemcitabine 1000 mg/m2 d1,8, IV” NCT06652022 ↗

“Gemcitabine with Nab Paclitaxel” NCT07044453 ↗

“GEMOX(Gemcitabine, Oxaliplatin)” NCT04239170 ↗

“GP (gemcitabine and cisplatin)” NCT02944708 ↗

“gemcitabine 1000mg/m2 iv D1,8” NCT03373019 ↗

“intravenous gemcitabine twice” NCT04627246 ↗

“gemcitabine 800 mg/m2 D1, D4” NCT05244642 ↗

“Gemcitabine + nab-paclitaxel” NCT02548169 ↗

“gemcitabine 1 g/m2 (30 min)” NCT00785421 ↗

“Gemcitabine :1g/m2 IV day 1” NCT04432402 ↗

“Gemcitabine, nab-Paclitaxel” NCT05601323 ↗

“gemcitabine (1000 mg/m², IV” NCT07638501 ↗

“Gemcitabine and Mitomycin C” NCT05701332 ↗

“Gemcitabine: 1000mg/m2, d1” NCT07279584 ↗

“gemcitabine 1g/m2, iv d1,8” NCT06062641 ↗

“gemcitabine + capecitabine” NCT06353646 ↗

“Gemcitabine and cisplatin” NCT05116891 ↗

“with gemcitabine infusion” NCT06370663 ↗

“Gemcitabine for injection” NCT04680988 ↗

“Cisplatin and Gemcitabine” NCT03930498 ↗

“with Gemcitabine 400mg/㎡” NCT01458717 ↗

“gemcitabine oxliplatin” NCT00561301 ↗

“Gemcitabine: 1000mg/m2” NCT07122609 ↗

“gemcitabine + platinum” NCT00391586 ↗

“11. hENT: Gemcitabine” NCT02101385 ↗

“Gemzar (Gemcitabine)” NCT00557492 ↗

“Gemzar (Gemcitabine)” NCT00055432 ↗

“Gemcitabine: 1.0g/m2” NCT05340491 ↗

“Gemcitabine (Gemzar)” NCT03138720 ↗

“gemcitabine (1000 mg” NCT07230626 ↗

“Gemcitabine (Gemzar)” NCT03415854 ↗

“gemcitabine: Gemzar” NCT01342224 ↗

“Drug: Gemcitabine” NCT03872947 ↗

“Drug: Gemcitabine” NCT02885974 ↗

“Drug: Gemcitabine” NCT05776524 ↗

“Drug: Gemcitabine” NCT01921751 ↗

“Gemcitabine：1g/m2” NCT02862587 ↗

“Drug: Gemcitabine” NCT02511132 ↗

“Drug: Gemcitabine” NCT04652206 ↗

“Gemcitabine (IV)” NCT05147272 ↗

“Gemcitabine” NCT00268242 ↗

“Gemcitabine” NCT03079427 ↗

“Gemcitabine” NCT05347134 ↗

“Gemcitabine” NCT01703910 ↗

“gemcitabine” NCT06983743 ↗

“gemcitabine” NCT07214779 ↗

“Gemcitabine” NCT04054362 ↗

NCT00403130 ↗

NCT06156514 ↗

NCT04377048 ↗

NCT00270907 ↗

NCT02405585 ↗

NCT03233139 ↗

NCT00173888 ↗

NCT02529579 ↗

NCT00902291 ↗

NCT06086197 ↗

NCT00055601 ↗

NCT01834235 ↗

NCT04447612 ↗

NCT00173862 ↗

NCT00055835 ↗

NCT00055887 ↗

NCT00247416 ↗

NCT07348107 ↗

NCT00271271 ↗

NCT00425360 ↗

NCT00670878 ↗

NCT06103864 ↗

NCT06041035 ↗

NCT00055965 ↗

NCT00585689 ↗

NCT06608927 ↗

NCT01702714 ↗

NCT00003316 ↗

NCT00454649 ↗

NCT00376948 ↗

NCT00055250 ↗

NCT05415917 ↗

NCT06956716 ↗

NCT04807816 ↗

NCT01043172 ↗

NCT01531712 ↗

NCT02037230 ↗

NCT00003332 ↗

NCT00246974 ↗

NCT01447225 ↗

NCT02331251 ↗

NCT00744640 ↗

NCT01145456 ↗

NCT00057798 ↗

NCT00003342 ↗

NCT04802980 ↗